This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Joshua Brooks, PhD
Associate Director at Alnylam Pharmaceuticals


Josh is an Associate Director at Alnylam Pharmaceuticals and leads the process characterization group. He received his Ph.D. in organic chemistry in the lab of Alison Frontier at the University of Rochester in 2012, and then completed his postdoctoral training working with Derek Tan at Memorial Sloan Kettering. He then joined the process chemistry group at Ionis pharmaceuticals before moving to the process group at Alnylam.

Agenda Sessions

  • Guanosine Related Impurities Resulting from Treatment with Diethylamine